The Latest Breaking News on Mental health

How one health concern could predict Alzheimer’s disease decades before first symptoms occur

Alzheimer’s disease affects millions of Americans and is one of the top 10 causes of death in the U.S.

The Independent UK · Dec 2, 2024

What is brain rot and how is mindlessly scrolling on social media impacting your mental health?

TikTok inspires 19th century term’s surprising comeback

Evening Standard · Dec 2, 2024

Depression May Trigger Severe Period Pain, Sleep Disturbances May Aggravate It: Study

A recent study found that depression may actually trigger severe period pain, with sleep deprivation worsening its severity.

Medical Daily · Dec 2, 2024

What is ADHD, how do you get a diagnosis and can you only treat it with drugs? All your questions, answered by experts

Attention deficit hyperactivity disorder affects about 2.6 million people in the UK, yet misinformation about the condition is rife. Here we separate scientific fact from TikTok-fuelled fiction

The Guardian - UK · Nov 29, 2024

The challenge of managing ADHD and money

Doctors don't even know it's a symptom

Salon · Nov 29, 2024

Nick Cannon admits 'I need help' following narcissistic personality disorder diagnosis

Nick Cannon has embraced getting "help" and working on himself after being diagnosed with narcissistic personality disorder.

BANG Premier · Nov 29, 2024

Depression may cause period pain, study suggests

The findings indicate the need for a holistic approach when treating mental health and reproductive issues, researchers say.

The Independent UK · Nov 27, 2024

Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce

Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is cut by 17%.

Benzinga · Nov 26, 2024

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial

IGC Pharma, Inc.(NYSE:IGC) reported additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1 for agitation in dementia associated with Alzheimer's disease. IGC-AD1 targets neuro-inflammation and CB1 receptor dysfunction,. The investigational drug contains THC as one of two active pharmaceutical agents. 

Benzinga · Nov 26, 2024

Making bullying everyone’s concern reduces rates in English and Welsh primary schools – new research

Bullying in schools is widespread, and it has consequences that can last through childhood and into adulthood. Research has found that children who are frequently bullied are more likely to self-harm, and being bullied in childhood has been linked with a higher risk of depression as an adult.

The Conversation · Nov 26, 2024